欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2172/001
药品名称
Oxaliplatin Eugia
活性成分
Oxaliplatin 5.0 mg/ml
剂型
Concentrate for solution for infusion
上市许可持有人
Eugia Pharma (Malta) Limited
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Spain (ES)
Portugal (PT)
Italy (IT)
Poland (PL)
Oxaliplatin Aurovitas
Germany (DE)
OXALIPLATIN PUREN 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Belgium (BE)
France (FR)
许可日期
2022/11/09
最近更新日期
2024/09/25
药物ATC编码
L01XA03 oxaliplatin
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR Summary
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20210802000069
Date of last change:2024/09/06
PubAR
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20210802000069_2
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase